Novel platelet antiaggregants and the changing landscape of stroke prevention.
Publication
, Journal Article
Goldstein, LB
Published in: Lancet Neurol
August 2011
Duke Scholars
Published In
Lancet Neurol
DOI
EISSN
1474-4465
Publication Date
August 2011
Volume
10
Issue
8
Start / End Page
678 / 680
Location
England
Related Subject Headings
- Stroke
- Platelet Aggregation Inhibitors
- Neurology & Neurosurgery
- Humans
- Controlled Clinical Trials as Topic
- Aspirin
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Goldstein, L. B. (2011). Novel platelet antiaggregants and the changing landscape of stroke prevention. Lancet Neurol, 10(8), 678–680. https://doi.org/10.1016/S1474-4422(11)70151-X
Goldstein, Larry B. “Novel platelet antiaggregants and the changing landscape of stroke prevention.” Lancet Neurol 10, no. 8 (August 2011): 678–80. https://doi.org/10.1016/S1474-4422(11)70151-X.
Goldstein LB. Novel platelet antiaggregants and the changing landscape of stroke prevention. Lancet Neurol. 2011 Aug;10(8):678–80.
Goldstein, Larry B. “Novel platelet antiaggregants and the changing landscape of stroke prevention.” Lancet Neurol, vol. 10, no. 8, Aug. 2011, pp. 678–80. Pubmed, doi:10.1016/S1474-4422(11)70151-X.
Goldstein LB. Novel platelet antiaggregants and the changing landscape of stroke prevention. Lancet Neurol. 2011 Aug;10(8):678–680.
Published In
Lancet Neurol
DOI
EISSN
1474-4465
Publication Date
August 2011
Volume
10
Issue
8
Start / End Page
678 / 680
Location
England
Related Subject Headings
- Stroke
- Platelet Aggregation Inhibitors
- Neurology & Neurosurgery
- Humans
- Controlled Clinical Trials as Topic
- Aspirin
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences